Broadcom: The AI Thesis Is Playing Out Faster Than Expected

Q1 AI semiconductor revenue jumped 106% y/y to $8.4B, with Q2 AI revenue guidance at $10.7B and management forecasting >$100B in AI chip revenue by 2027. An analyst upgrade to STRONG BUY set a base case price target of $462. Tomahawk 6 drove 60% y/y AI networking growth and Tomahawk 7, which doubles performance, is slated to launch in 2027.

Analysis

The market is pricing Broadcom as the dominant beneficiary of the AI infrastructure cycle, but the real second-order winner set spans equipment and materials upstream (advanced EUV node tools, substrate/OSAT capacity, HBM suppliers) and downstream (switch and optical OEMs that capture systems-level margin). Expect gross-margin upside to be nonlinear: each incremental rack-level compute uplift drives outsized networking and optics content per rack, concentrating TAM gains in a handful of large silicon- and board-level suppliers rather than a broad base of small vendors.

Competitive dynamics favor firms that can match scale and lead-time on advanced process nodes and diversified customer design wins; smaller switch-ASIC vendors and single-source OSAT partners face outsized risk of margin pressure or displacement. Hyperscalers’ propensity to internalize designs remains the largest latent threat — if one or two hyperscalers accelerate custom silicon for switching/telemetry, that could materially shorten Broadcom’s runway and shift spend toward in-house engineering and different suppliers.

Key timing layers: stock moves are driven by near-term quarterly bookings/inventory cadence (days–months), product cadence and foundry roadmap alignment (6–24 months), and architectural shifts or customer vertical integration (2–5 years). A reversal would likely be signaled by a sustained deceleration in hyperscaler capex cadence, visible inventory digestion at major customers, or a cadence miss from advanced-fab suppliers that eases pricing power across the stack.

From a macro-portfolio perspective, allocate exposure via differentiated instruments rather than full equity risk: own scalable exposure to the consolidated winners while hedging cyclical inventory/ASP risk, and watch signals at the supply-chain nodes (equipment lead times, HBM contracts, OSAT utilization) as high-signal catalysts for de-risking or scaling positions.

Key Decisions for Investors

• Long AVGO via calendar call spread (buy 12-18 month call, sell nearer-dated call) to capture multi-quarter structural upside while funding theta decay; target an initial position of 1–2% NAV, taking profits if IV falls >30% or if quarterly bookings lag guidance by >10%
• Pairs trade: long ASML (ASML) or LRCX for equipment-exposure and short a smaller networking-ASIC peer (MRVL) to play scale consolidation — 6–18 month horizon, expect asymmetric payoff if node lead-times remain tight; keep size balanced (dollar-neutral) and tighten stops if tape indicates hyperscaler vertical integration acceleration
• Options income trade: sell 30–45 day covered calls on existing AVGO exposure after earnings prints where IV spikes, capturing premium while remaining exposed to longer-term secular gains; cap upside at strike ~10–15% above spot and roll if material guidance upgrades persist
• Event-based hedge: buy 6–12 month out-of-the-money puts on AVGO (or index puts on SOXX) sized to cap downside from an inventory/weak-bookings shock; unwind if supply-chain lead indicators (OSAT utilisation, ASML shipments, HBM contract announcements) remain strong at next two quarterly checks